<DOC>
	<DOCNO>NCT00812045</DOCNO>
	<brief_summary>The purpose study determine effect AZD1236 patient cystic fibrosis ( CF ) inflammatory biomarkers induce sputum , treatment period 4 week .</brief_summary>
	<brief_title>Study Assess Efficacy AZD1236 Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Have clinical diagnosis cystic fibrosis FEV1 &gt; 40 % predict normal Be able comply induce sputum procedure postmenopausal surgically sterile female ( total hysterectomy /or bilateral total oophorectomy ) Concomitant diagnosis significant pulmonary disease CFrelated lung disease , include symptomatic asthma allergic bronchopulmonary aspergillosis Treatment immunomodulatory agent within 8 week prior Visit 2 Known infect Burkholderia cepacia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Induced sputum</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>biomarker</keyword>
	<keyword>CYBER</keyword>
</DOC>